Hyams et al., 2010 - Google Patents
Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotypeHyams et al., 2010
View PDF- Document ID
- 12567775675573505695
- Author
- Hyams C
- Yuste J
- Bax K
- Camberlein E
- Weiser J
- Brown J
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
Streptococcus pneumoniae strains vary considerably in the ability to cause invasive disease in humans, and this is partially associated with the capsular serotype. The S. pneumoniae capsule inhibits complement-and phagocyte-mediated immunity, and differences between …
- 230000000295 complement 0 title abstract description 56
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hyams et al. | Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype | |
| Hyams et al. | The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms | |
| Fiore et al. | Pathogenicity of enterococci | |
| Hyams et al. | Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b | |
| Sierig et al. | Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci | |
| Keller et al. | Nonencapsulated Streptococcus pneumoniae: emergence and pathogenesis | |
| Nakano et al. | Demonstration of Streptococcus mutans with a cell wall polysaccharide specific to a new serotype, k, in the human oral cavity | |
| Neeleman et al. | Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H | |
| Choi et al. | Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies | |
| Melin et al. | Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B | |
| Skov Sørensen et al. | Capsular polysaccharide expression in commensal Streptococcus species: genetic and antigenic similarities to Streptococcus pneumoniae | |
| Wilson et al. | The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi | |
| Wardenburg et al. | Vaccine protection against Staphylococcus aureus pneumonia | |
| Tu et al. | Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae | |
| Briles et al. | Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci | |
| Kline et al. | Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection | |
| Vestrheim et al. | Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway | |
| Cumley et al. | The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages | |
| Zafar et al. | Capsule type and amount affect shedding and transmission of Streptococcus pneumoniae | |
| Thiolas et al. | Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient | |
| Hyams et al. | Effects of Streptococcus pneumoniae strain background on complement resistance | |
| Ren et al. | The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro | |
| Hu et al. | Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae | |
| Bitzan et al. | Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers | |
| Sanchez et al. | Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence |